Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.720
+0.090 (1.94%)
At close: Sep 26, 2025, 4:00 PM EDT
4.720
0.00 (0.00%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.06 billion as of September 26, 2025. Its market cap has increased by 13.83% in one year.
Market Cap
2.06B
Enterprise Value
1.63B
1-Year Change
13.83%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.06B, a decrease of -59.35%. That is a compound annual growth rate of -18.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 2.06B | -22.63% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 647.76B |
| Johnson & Johnson | 432.51B |
| AbbVie | 387.26B |
| UnitedHealth Group | 312.00B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.96B |
| AstraZeneca | 226.78B |